title: [Pharmacokinetic monitoring as a new tool to individualize anti-TNF therapy].
authors.affiliation: Servicio de Farmacia. Xerencia Xestión Integrada. A Coruña. España.. laida.elberdin.pazos@sergas.es.
authors.forename: Laida
authors.initials: L
authors.lastname: Elberdín Pazos
authors.affiliation: Servicio de Farmacia. Xerencia Xestión Integrada. A Coruña. España.. maria.outeda.macias@sergas.es.
authors.forename: María
authors.initials: M
authors.lastname: Outeda Macías
authors.affiliation: Servicio de Farmacia. Xerencia Xestión Integrada. A Coruña. España.. laida.elberdin.pazos@sergas.es.
authors.forename: Pilar
authors.initials: P
authors.lastname: Salvador Garrido
authors.affiliation: Servicio de Farmacia. Xerencia Xestión Integrada. A Coruña. España.. laida.elberdin.pazos@sergas.es.
authors.forename: María Isabel
authors.initials: MI
authors.lastname: Martín Herranz
mesh_terms: D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy; D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab